amifostine anhydrous and levamisole

amifostine anhydrous has been researched along with levamisole in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Rivoire, M1
Brown, DQ; Gold, J; Hardiman, J; Mann, DJ; Pittock, JW; Pogach, R; Shaw, LM1

Other Studies

3 other study(ies) available for amifostine anhydrous and levamisole

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
[Cancers of the colon and the rectum: news in 1992].
    Pathologie-biologie, 1992, Volume: 40, Issue:9 Pt 2

    Topics: Amifostine; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Rectal Neoplasms

1992
Modification of WR-2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:8

    Topics: Alkaline Phosphatase; Amifostine; Animals; Biotransformation; Levamisole; Mercaptoethylamines; Mice; Organothiophosphorus Compounds; Radiation-Protective Agents

1986